Home Applications 210929 Application 210929
Type ANDA
Sponsor HANGZHOU ZHONGMEI Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TACROLIMUS TACROLIMUS CAPSULE;ORAL EQ 0.5MG BASE No No 002 TACROLIMUS TACROLIMUS CAPSULE;ORAL EQ 1MG BASE No No 003 TACROLIMUS TACROLIMUS CAPSULE;ORAL EQ 5MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210929-001 TACROLIMUS TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL 2023-04-17 A210929-002 TACROLIMUS TACROLIMUS EQ 1MG BASE CAPSULE / ORAL 2023-04-17 A210929-003 TACROLIMUS TACROLIMUS EQ 5MG BASE CAPSULE / ORAL 2023-04-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 69 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL 2023-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL 2023-04-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL 2023-04-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL 2023-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL 2023-04-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL 2023-04-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL 2023-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL 2023-04-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL 2023-04-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL 2023-04-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL 2023-04-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL 2023-04-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210929-002 TACROLIMUS EQ 1MG BASE CAPSULE / ORAL AB 2023-04-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210929-003 TACROLIMUS EQ 5MG BASE CAPSULE / ORAL AB 2023-04-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210929-001 TACROLIMUS EQ 0.5MG BASE CAPSULE / ORAL AB 2023-04-17 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 54 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Tacrolimus TACROLIMUS Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd 759cf905-7406-4d1b-a1a8-10068cb11f04 2025-07-11 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210929 application number: ANDA210929